IBDEI1GI ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23558,1,3,0)
;;=3^Personal Hx of Nicotine Dependence
;;^UTILITY(U,$J,358.3,23558,1,4,0)
;;=4^Z87.891
;;^UTILITY(U,$J,358.3,23558,2)
;;=^5063518
;;^UTILITY(U,$J,358.3,23559,0)
;;=E13.9^^79^1017^9
;;^UTILITY(U,$J,358.3,23559,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23559,1,3,0)
;;=3^Diabetes Mellitus w/o Complications,Other Spec
;;^UTILITY(U,$J,358.3,23559,1,4,0)
;;=4^E13.9
;;^UTILITY(U,$J,358.3,23559,2)
;;=^5002704
;;^UTILITY(U,$J,358.3,23560,0)
;;=R94.8^^79^1017^4
;;^UTILITY(U,$J,358.3,23560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23560,1,3,0)
;;=3^Abnormal Results of Function Studies of Organs/Systems
;;^UTILITY(U,$J,358.3,23560,1,4,0)
;;=4^R94.8
;;^UTILITY(U,$J,358.3,23560,2)
;;=^5019745
;;^UTILITY(U,$J,358.3,23561,0)
;;=Z63.4^^79^1017^7
;;^UTILITY(U,$J,358.3,23561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23561,1,3,0)
;;=3^Bereavement
;;^UTILITY(U,$J,358.3,23561,1,4,0)
;;=4^Z63.4
;;^UTILITY(U,$J,358.3,23561,2)
;;=^5063168
;;^UTILITY(U,$J,358.3,23562,0)
;;=Z45.2^^79^1017^5
;;^UTILITY(U,$J,358.3,23562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23562,1,3,0)
;;=3^Adjustment & Management of VAD
;;^UTILITY(U,$J,358.3,23562,1,4,0)
;;=4^Z45.2
;;^UTILITY(U,$J,358.3,23562,2)
;;=^5062999
;;^UTILITY(U,$J,358.3,23563,0)
;;=Z76.0^^79^1017^18
;;^UTILITY(U,$J,358.3,23563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23563,1,3,0)
;;=3^Issue of Repeat Prescription
;;^UTILITY(U,$J,358.3,23563,1,4,0)
;;=4^Z76.0
;;^UTILITY(U,$J,358.3,23563,2)
;;=^5063297
;;^UTILITY(U,$J,358.3,23564,0)
;;=Z01.818^^79^1017^26
;;^UTILITY(U,$J,358.3,23564,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23564,1,3,0)
;;=3^Pre-Op Call
;;^UTILITY(U,$J,358.3,23564,1,4,0)
;;=4^Z01.818
;;^UTILITY(U,$J,358.3,23564,2)
;;=^5062628
;;^UTILITY(U,$J,358.3,23565,0)
;;=Z51.81^^79^1017^27
;;^UTILITY(U,$J,358.3,23565,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23565,1,3,0)
;;=3^Therapeutic Drug Level Monitoring
;;^UTILITY(U,$J,358.3,23565,1,4,0)
;;=4^Z51.81
;;^UTILITY(U,$J,358.3,23565,2)
;;=^5063064
;;^UTILITY(U,$J,358.3,23566,0)
;;=I10.^^79^1017^17
;;^UTILITY(U,$J,358.3,23566,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23566,1,3,0)
;;=3^Hypertension
;;^UTILITY(U,$J,358.3,23566,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,23566,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,23567,0)
;;=Z79.01^^79^1017^20
;;^UTILITY(U,$J,358.3,23567,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23567,1,3,0)
;;=3^Long Term (Current) Use of Anticoagulants
;;^UTILITY(U,$J,358.3,23567,1,4,0)
;;=4^Z79.01
;;^UTILITY(U,$J,358.3,23567,2)
;;=^5063330
;;^UTILITY(U,$J,358.3,23568,0)
;;=R73.09^^79^1017^3
;;^UTILITY(U,$J,358.3,23568,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23568,1,3,0)
;;=3^Abnormal Glucose
;;^UTILITY(U,$J,358.3,23568,1,4,0)
;;=4^R73.09
;;^UTILITY(U,$J,358.3,23568,2)
;;=^5019563
;;^UTILITY(U,$J,358.3,23569,0)
;;=R68.89^^79^1017^13
;;^UTILITY(U,$J,358.3,23569,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23569,1,3,0)
;;=3^General Symptoms & Signs
;;^UTILITY(U,$J,358.3,23569,1,4,0)
;;=4^R68.89
;;^UTILITY(U,$J,358.3,23569,2)
;;=^5019557
;;^UTILITY(U,$J,358.3,23570,0)
;;=R79.89^^79^1017^1
;;^UTILITY(U,$J,358.3,23570,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23570,1,3,0)
;;=3^Abnormal Findings of Blood Chemistry
;;^UTILITY(U,$J,358.3,23570,1,4,0)
;;=4^R79.89
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1GI 3759 printed Apr 09, 2024@22:00:45 Page 2
IBDEI1GI ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23558,1,3,0)
+2 ;;=3^Personal Hx of Nicotine Dependence
+3 ;;^UTILITY(U,$J,358.3,23558,1,4,0)
+4 ;;=4^Z87.891
+5 ;;^UTILITY(U,$J,358.3,23558,2)
+6 ;;=^5063518
+7 ;;^UTILITY(U,$J,358.3,23559,0)
+8 ;;=E13.9^^79^1017^9
+9 ;;^UTILITY(U,$J,358.3,23559,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,23559,1,3,0)
+12 ;;=3^Diabetes Mellitus w/o Complications,Other Spec
+13 ;;^UTILITY(U,$J,358.3,23559,1,4,0)
+14 ;;=4^E13.9
+15 ;;^UTILITY(U,$J,358.3,23559,2)
+16 ;;=^5002704
+17 ;;^UTILITY(U,$J,358.3,23560,0)
+18 ;;=R94.8^^79^1017^4
+19 ;;^UTILITY(U,$J,358.3,23560,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,23560,1,3,0)
+22 ;;=3^Abnormal Results of Function Studies of Organs/Systems
+23 ;;^UTILITY(U,$J,358.3,23560,1,4,0)
+24 ;;=4^R94.8
+25 ;;^UTILITY(U,$J,358.3,23560,2)
+26 ;;=^5019745
+27 ;;^UTILITY(U,$J,358.3,23561,0)
+28 ;;=Z63.4^^79^1017^7
+29 ;;^UTILITY(U,$J,358.3,23561,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,23561,1,3,0)
+32 ;;=3^Bereavement
+33 ;;^UTILITY(U,$J,358.3,23561,1,4,0)
+34 ;;=4^Z63.4
+35 ;;^UTILITY(U,$J,358.3,23561,2)
+36 ;;=^5063168
+37 ;;^UTILITY(U,$J,358.3,23562,0)
+38 ;;=Z45.2^^79^1017^5
+39 ;;^UTILITY(U,$J,358.3,23562,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,23562,1,3,0)
+42 ;;=3^Adjustment & Management of VAD
+43 ;;^UTILITY(U,$J,358.3,23562,1,4,0)
+44 ;;=4^Z45.2
+45 ;;^UTILITY(U,$J,358.3,23562,2)
+46 ;;=^5062999
+47 ;;^UTILITY(U,$J,358.3,23563,0)
+48 ;;=Z76.0^^79^1017^18
+49 ;;^UTILITY(U,$J,358.3,23563,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,23563,1,3,0)
+52 ;;=3^Issue of Repeat Prescription
+53 ;;^UTILITY(U,$J,358.3,23563,1,4,0)
+54 ;;=4^Z76.0
+55 ;;^UTILITY(U,$J,358.3,23563,2)
+56 ;;=^5063297
+57 ;;^UTILITY(U,$J,358.3,23564,0)
+58 ;;=Z01.818^^79^1017^26
+59 ;;^UTILITY(U,$J,358.3,23564,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,23564,1,3,0)
+62 ;;=3^Pre-Op Call
+63 ;;^UTILITY(U,$J,358.3,23564,1,4,0)
+64 ;;=4^Z01.818
+65 ;;^UTILITY(U,$J,358.3,23564,2)
+66 ;;=^5062628
+67 ;;^UTILITY(U,$J,358.3,23565,0)
+68 ;;=Z51.81^^79^1017^27
+69 ;;^UTILITY(U,$J,358.3,23565,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,23565,1,3,0)
+72 ;;=3^Therapeutic Drug Level Monitoring
+73 ;;^UTILITY(U,$J,358.3,23565,1,4,0)
+74 ;;=4^Z51.81
+75 ;;^UTILITY(U,$J,358.3,23565,2)
+76 ;;=^5063064
+77 ;;^UTILITY(U,$J,358.3,23566,0)
+78 ;;=I10.^^79^1017^17
+79 ;;^UTILITY(U,$J,358.3,23566,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,23566,1,3,0)
+82 ;;=3^Hypertension
+83 ;;^UTILITY(U,$J,358.3,23566,1,4,0)
+84 ;;=4^I10.
+85 ;;^UTILITY(U,$J,358.3,23566,2)
+86 ;;=^5007062
+87 ;;^UTILITY(U,$J,358.3,23567,0)
+88 ;;=Z79.01^^79^1017^20
+89 ;;^UTILITY(U,$J,358.3,23567,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,23567,1,3,0)
+92 ;;=3^Long Term (Current) Use of Anticoagulants
+93 ;;^UTILITY(U,$J,358.3,23567,1,4,0)
+94 ;;=4^Z79.01
+95 ;;^UTILITY(U,$J,358.3,23567,2)
+96 ;;=^5063330
+97 ;;^UTILITY(U,$J,358.3,23568,0)
+98 ;;=R73.09^^79^1017^3
+99 ;;^UTILITY(U,$J,358.3,23568,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,23568,1,3,0)
+102 ;;=3^Abnormal Glucose
+103 ;;^UTILITY(U,$J,358.3,23568,1,4,0)
+104 ;;=4^R73.09
+105 ;;^UTILITY(U,$J,358.3,23568,2)
+106 ;;=^5019563
+107 ;;^UTILITY(U,$J,358.3,23569,0)
+108 ;;=R68.89^^79^1017^13
+109 ;;^UTILITY(U,$J,358.3,23569,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,23569,1,3,0)
+112 ;;=3^General Symptoms & Signs
+113 ;;^UTILITY(U,$J,358.3,23569,1,4,0)
+114 ;;=4^R68.89
+115 ;;^UTILITY(U,$J,358.3,23569,2)
+116 ;;=^5019557
+117 ;;^UTILITY(U,$J,358.3,23570,0)
+118 ;;=R79.89^^79^1017^1
+119 ;;^UTILITY(U,$J,358.3,23570,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,23570,1,3,0)
+122 ;;=3^Abnormal Findings of Blood Chemistry
+123 ;;^UTILITY(U,$J,358.3,23570,1,4,0)
+124 ;;=4^R79.89
